ExpreS2ion Biotech Holding AB Capital Reinvestment Ratio

Latest as of March 2024: 0.22x

ExpreS2ion Biotech Holding AB capital reinvestment ratio. ExpreS2ion Biotech Holding AB (EXPRS2) has a Capital Reinvestment Ratio of 0.22x as of March 2024, meaning it reinvests 0% of its operating cash flow (Skr854.00K) in capital expenditures (Skr189.00K). Check ExpreS2ion Biotech Holding AB (EXPRS2) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.22x

Capex / Operating Cash Flow

Operating Cash Flow

Skr854.00K

SEK

Capital Expenditures

Skr189.00K

SEK

Data as of

Mar 2024

Most recent filing

ExpreS2ion Biotech Holding AB Capital Reinvestment Ratio by Year (None–None)

ExpreS2ion Biotech Holding AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of ExpreS2ion Biotech Holding AB.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow